Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis-Reference-Cited by-同舟云学术

Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis

Published:2020-02-21 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Liu Xiao-bo,Gao Zi-ye,Zhang Qing-hui,Pandey Sandeep,Gao Bo,Yang Fan,Tong Qiang,Li Sheng-bao

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference47 articles.

1. Classification of adenocarcinoma of the oesophagogastric junction;Siewert;Br J Surg.,1998

2. Regional variations in esophageal cancer rates by census region in the United States, 1999–2008;Drahos;PLoS ONE.,2013

3. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?-a SEER database analysis;Dubecz;J Gastrointest Surg.,2014

4. Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries;Hatta;Dig Endosc.,2017

5. Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988–2012: a single-institution, high-volume experience in China;Liu;Ann Surg.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy;Langenbeck's Archives of Surgery;2023-06-06

2. Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction;World Journal of Gastrointestinal Surgery;2022-08-27

3. Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta‐analysis;Cancer Medicine;2022-06-12

4. Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma;ESMO Open;2021-02